Improve MRI Diagnosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

2016 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-15

Study Completion Date

2030-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of the research is to compare by two blind evaluators new MRI techniques with routinely used sequences.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Test and Optimization of New Specific MRI Sequences on an Imager Dedicated to Research

NCT03674645

Magnetic Resonance Imaging Sequences

UNKNOWN NA

Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging in Normal Volunteers

NCT00720460

Healthy

TERMINATED

Magnetic Resonance Imaging (MRI) Analysis of Coronary Artery Plaque Components

NCT00559728

Coronary Artery Plaque Components

COMPLETED

MRI Technical Development and Applications in Kidney Disease

NCT02421497

Chronic Kidney Diseases Kidney Transplantation Dialysis +1 more

NOT_YET_RECRUITING

Development of 3T Magnetic Resonance Research Methods for NIA Studies

NCT01324206

Normal Physiology

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

"The main evaluation criterion will be the choice of the two (or three) evaluators as to the best sequence between the new sequence and the standard sequence.

The decision criterion for considering a new sequence as superior to the standard sequence will be based on two measures:

1. The proportion of patients for whom the new sequence was preferred, which must be greater than or equal to 75%;
2. Inter-observer agreement (Cohen's Kappa coefficient), which must be greater than or equal to 0.8; When these two criteria are met, the new sequence will be considered superior to the standard sequence"

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

New MRI Techniques

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adult patients having MRI planned at Paul Brousse Hospital

Evaluate new MRI sequences on a population of patients undergoing MRI as part of their usual care

Group Type OTHER

MRI Image

Intervention Type DIAGNOSTIC_TEST

MRI sequences

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MRI Image

MRI sequences

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patient
* Patient who signed a consent to participate in the study
* Affiliated patient or beneficiary of a social security scheme
* Patient having an MRI scheduled as part of their care pathway
* Absence of prohibition of participation in another research

Exclusion Criteria

* Patients under guardianship or curators
* Pregnant or breastfeeding patients
* Patients responding to a contraindication to performing an MRI
* Patient under state medical aid (AME)
* Adult patients protected by law

Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No